? Prostaglandin D2 (PGD2) is a major cyclooxygenase metabolite, and its release has been hypothesized to contribute to the inflammation and increased airway hyperreactivity observed in asthma. PGD2 appears to act in part through a recently cloned GPCR designated CRTH2. CRTH2 mRNA expression pattern is consistent with an important role for this receptor in the etiology of allergic disease. The principal hypothesis of this proposal is that critical PGD2 evoked changes in the immune inflammatory response are mediated, at least in part, by CRTH2-evoked responses. We further propose that some of the effects of PGD2 metabolites including PGJ2 and 15d PGJ2 are mediated via the CRTH2 receptor. To test this hypothesis we propose in Specific Aim 1 to define the pharmacology of the mouse CRTH2 receptor. We will express the CRTH2 receptor in cell culture and determine its ligand binding and signal transduction properties.
In Specific Aim 2 we will identify amino acid residues critical for ligand binding and signal transduction by site directed mutagenesis. Using modeling and molecular dynamics simulations as a guide, we will introduce point mutations into the CRTH2 receptor, and express mutant receptors in cell culture systems.
In Specific Aim 3 we will explore whether PGD2 modulates inflammatory effects and/or bronchoconstriction in mouse models of asthma via the CRTH2 receptor. We will analyze ovalbumin (OVA) allergic sensitization, a TH2 type immune model, in CRTH2 knockout mice and compare this with DP null animals. We further propose to cross the CRTH2 null mice with DP null mice to test the effect of loss of both PGD2 receptors. Completion of these studies should aid in the elucidation of the physiologic role of PGD2 in cellular migration and infiltration in allergic airway disease and will provide insight as to the role of this receptor in mouse models of allergic inflammation. ? ? ?
| Lotz, Matthew T; Moore, Martin L; Peebles Jr, R Stokes (2013) Respiratory syncytial virus and reactive airway disease. Curr Top Microbiol Immunol 372:105-18 |
| Newcomb, Dawn C; Peebles Jr, R Stokes (2013) Th17-mediated inflammation in asthma. Curr Opin Immunol 25:755-60 |
| Toki, Shinji; Goleniewska, Kasia; Huckabee, Matthew M et al. (2013) PGI? signaling inhibits antigen uptake and increases migration of immature dendritic cells. J Leukoc Biol 94:77-88 |
| Newcomb, Dawn C; Boswell, Madison G; Sherrill, Taylor P et al. (2013) IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia. Am J Respir Cell Mol Biol 48:711-6 |
| Newcomb, Dawn Catherine; Boswell, Madison G; Reiss, Sara et al. (2013) IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax 68:717-23 |
| Zhou, Weisong; Dowell, Dustin R; Huckabee, Matthew M et al. (2012) Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis. PLoS One 7:e33518 |
| Newcomb, Dawn C; Boswell, Madison G; Huckabee, Matthew M et al. (2012) IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J Immunol 188:1027-35 |
| Dorris, Stacy L; Peebles Jr, R Stokes (2012) PGI2 as a regulator of inflammatory diseases. Mediators Inflamm 2012:926968 |
| Lotz, Matthew T; Peebles Jr, R Stokes (2012) Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr Allergy Asthma Rep 12:380-7 |
| Dulek, Daniel E; Peebles Jr, R Stokes (2011) Viruses and asthma. Biochim Biophys Acta 1810:1080-90 |
Showing the most recent 10 out of 15 publications
